Emergen Research Logo

Market Trend – Advancement in technology.

VANCOUVER, BC, UNITED STATES, May 4, 2022 /EINPresswire.com/ -- The global next-generation biomanufacturing market is expected to reach a market size of USD 39.18 Billion by 2028, according to a recent analysis by Emergen Research. Next-generation biomanufacturing process makes it possible to meet increasing demand for biological medicine used in the treatment of critical diseases such as liver and kidney disorders, cancer and diabetes. In addition, growing adoption of single-use products such as single-use bio-reactors, bio containers and increasing financial support from private investors and governments for development of next-generation biomanufacturing units are among some major factors driving growth of the global next-generation biomanufacturing market, and the trend is expected to continue over the forecast period.

Next-generation biomanufacturing process uses advanced technologies such as Artificial Intelligence, augmented reality, etc., and offers seamless outcomes that are better in terms of quality compared to outcomes generated using first-generation process. The adoption rate of next-generation biomanufacturing process is growing among various biopharmaceutical companies and research institutes owing to more energy-efficiency reduced water requirement, less volume of solid waste, and comparatively lower carbon emissions in the environment.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/504

The study offers comprehensive coverage of the qualitative and quantitative analysis of the Next-Generation Biomanufacturing market along with crucial statistical data about the Next-Generation Biomanufacturing market. The research study provides historical data and offers accurate forecast estimation until 2030. The report also profiles established and emerging players of the market, covering the business overview, product portfolio, strategic alliances, and business expansion strategies.

Key players operating in the market are Merck KGaA, Thermo Fisher Scientific Inc., Eppendorf AG, Danaher Corporation, GEA Group Aktiengesellschaft, Sartorius AG, bbi-biotech GmbH, Solaris Biotechnology Srl, Esco Group of Companies, Pierre Guérin, and PBS Biotech, Inc.

Highlights from the Report

In July 2018, Amgen opened a new next-generation biomanufacturing plant located in West Greenwich, R.I. campus. The company invested approximately USD 200 Million in this new facility.

In April 2020, Akron Biotech acquired Cambryn in Sarasota, Florida, from Cambryn Biologics. The facility is a biomanufacturing plant equipped with state-of-the-art equipment.

Biopharmaceutical Companies accounted for a 39% revenue share in the global market. This can be attributed to rapid technological advancements and increasing investor and governments funding.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/504

The report is an investigative study of the technological developments and product advancements, along with a regional analysis for each product and application offered in the market. The fundamental objective of the report is to give an insight into the workings of the Next-Generation Biomanufacturing industry. It provides an accurate and strategic outlook of the market with a thorough assessment of the segments and sub-segments of the market. It provides a panoramic view of the industry to offer a deeper understanding of the global industry.

For the purpose of this report, Emergen Research has segmented the next-generation biomanufacturing market based on type, application, end-use, and region as follows:

Type Outlook (Revenue: USD Billion; 2020–-2028)

Continuous Upstream Biomanufacturing

Single-Use Upstream Biomanufacturing

Downstream Biomanufacturing

Application Outlook (Revenue: USD Billion; 2020–-2028)

Monoclonal Antibodies

Hormones

Vaccines

Recombinant Proteins

Others

End-Use Outlook (Revenue: USD Billion; 2020–-2028)

Biopharmaceutical Companies

Research Institutions

CMOs/CDMOs

The complete regional analysis covers:

North America (U.S., Canada, Mexico

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

The report offers a comprehensive understanding of the impact of the COVID-19 pandemic on the overall market growth and expansion. COVID-19 has affected the global economy by interfering with production and demand, causing market disruption, and inducing financial instability.

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/504

Key Points of Next-Generation Biomanufacturing Market:

Extensive coverage of the analysis of the Next-Generation Biomanufacturing market

Key insights into the regional spread of the industry in key geographies

Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market

Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Next-Generation Biomanufacturing market

Complete data about the key manufacturers and vendors in the Next-Generation Biomanufacturing market

Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.

Take a Look at our Related Reports:

Smart Farming Market https://www.emergenresearch.com/industry-report/smart-farming-market

Patient Engagement Solutions Market https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

NGS Sample Preparation Market https://www.emergenresearch.com/industry-report/ngs-sample-preparation-market

Synthetic Food Market https://www.emergenresearch.com/industry-report/synthetic-food-market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.